Baxter International Inc
BAX23.810USD
-0.180-0.75%
收盘 09/15, 16:00（美东）报价延迟15分钟
12.23B总市值
亏损市盈率 TTM
关于 Baxter International Inc 公司
百特国际公司是一家全球医疗科技公司。其部门包括医疗产品和疗法、医疗保健系统和技术以及制药。医疗产品和疗法部门包括其无菌静脉注射液、输液系统、给药装置、肠外营养疗法和手术止血剂、密封剂和防粘连产品的销售。医疗保健系统和技术部门包括其互联护理解决方案和协作工具的销售，包括智能床系统、患者监测系统和诊断技术、呼吸健康设备和先进的手术空间设备，包括手术室集成技术、精密定位设备和其他配件。制药部门包括特种注射药物、吸入麻醉和药物配制的销售。它提供诊断、重症监护、营养、医院和外科产品组合。
公司简介
公司代码BAX
公司名称Baxter International Inc
上市日期May 15, 1961
CEOMr. Andrew P. Hider
员工数量38000
证券类型Ordinary Share
年结日May 15
公司地址One Baxter Parkway
城市DEERFIELD
上市交易所NYSE Consolidated
国家United States of America
邮编60015
电话12249482000
网址https://www.baxter.com/
公司代码BAX
上市日期May 15, 1961
CEOMr. Andrew P. Hider
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
368.05K
--
Ms. Heather Knight
Ms. Heather Knight
Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies
Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies
177.32K
+11.79%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.67K
+7.47%
Mr. Alok Sonig
Mr. Alok Sonig
Executive Vice President, Group President - Pharmaceuticals
Executive Vice President, Group President - Pharmaceuticals
127.11K
-2.45%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
101.60K
-14.01%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
35.70K
+25.18%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+31.17%
Ms. Patricia B. (Patty) Morrison
Ms. Patricia B. (Patty) Morrison
Independent Director
Independent Director
22.94K
+45.58%
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Director
Independent Director
16.45K
+77.49%
Mr. Jeffrey A. (Jay) Craig
Mr. Jeffrey A. (Jay) Craig
Independent Director
Independent Director
10.65K
+206.88%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
368.05K
--
Ms. Heather Knight
Ms. Heather Knight
Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies
Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies
177.32K
+11.79%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.67K
+7.47%
Mr. Alok Sonig
Mr. Alok Sonig
Executive Vice President, Group President - Pharmaceuticals
Executive Vice President, Group President - Pharmaceuticals
127.11K
-2.45%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
101.60K
-14.01%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
35.70K
+25.18%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Infusion Therapies and Technologies
994.00M
37.87%
Care and Connectivity Solutions
427.00M
16.27%
Injectables and Anesthesia
335.00M
12.76%
Front Line Care
277.00M
10.55%
Advanced Surgery
268.00M
10.21%
其他
324.00M
12.34%
地区USD
名称
营收
占比
United States
1.49B
56.76%
International
1.14B
43.24%
业务
地区
业务USD
名称
营收
占比
Infusion Therapies and Technologies
994.00M
37.87%
Care and Connectivity Solutions
427.00M
16.27%
Injectables and Anesthesia
335.00M
12.76%
Front Line Care
277.00M
10.55%
Advanced Surgery
268.00M
10.21%
其他
324.00M
12.34%
股东统计
更新时间: 8月19日 周二
更新时间: 8月19日 周二
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
12.06%
Pzena Investment Management, LLC
10.80%
Dodge & Cox
10.15%
BlackRock Institutional Trust Company, N.A.
5.81%
State Street Global Advisors (US)
4.27%
其他
56.91%
持股股东
持股股东
占比
The Vanguard Group, Inc.
12.06%
Pzena Investment Management, LLC
10.80%
Dodge & Cox
10.15%
BlackRock Institutional Trust Company, N.A.
5.81%
State Street Global Advisors (US)
4.27%
其他
56.91%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
46.91%
Investment Advisor
44.39%
Hedge Fund
3.20%
Research Firm
2.06%
Pension Fund
1.76%
Insurance Company
1.45%
Bank and Trust
1.29%
Sovereign Wealth Fund
1.14%
Individual Investor
0.46%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
1877
507.74M
98.85%
-23.16M
2025Q1
1934
508.09M
99.01%
-37.41M
2024Q4
1984
501.11M
97.98%
-41.68M
2024Q3
2005
485.40M
95.14%
-42.32M
2024Q2
2042
472.72M
92.77%
-47.98M
2024Q1
2091
469.13M
92.11%
-57.76M
2023Q4
2137
471.69M
92.98%
-44.04M
2023Q3
2123
465.39M
91.91%
-35.52M
2023Q2
2140
458.55M
90.66%
-30.65M
2023Q1
2123
459.27M
90.86%
-22.24M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
60.82M
11.85%
+290.58K
+0.48%
Mar 31, 2025
Pzena Investment Management, LLC
36.77M
7.17%
+3.13M
+9.32%
Mar 31, 2025
Dodge & Cox
51.46M
10.03%
-122.48K
-0.24%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
30.27M
5.9%
+743.24K
+2.52%
Mar 31, 2025
State Street Global Advisors (US)
21.77M
4.24%
-21.20K
-0.10%
Mar 31, 2025
T. Rowe Price Associates, Inc.
19.57M
3.81%
+4.32M
+28.32%
Mar 31, 2025
BlackRock Financial Management, Inc.
17.99M
3.51%
+419.98K
+2.39%
Mar 31, 2025
Geode Capital Management, L.L.C.
12.56M
2.45%
+109.37K
+0.88%
Mar 31, 2025
Harris Associates L.P.
9.00M
1.75%
+540.70K
+6.39%
Mar 31, 2025
BlackRock Investment Management, LLC
6.99M
1.36%
+2.18M
+45.23%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Cullen Enhanced Equity Income ETF
2.77%
iShares Large Cap Value Active ETF
2.32%
First Trust Indxx Medical Devices ETF
1.96%
iShares U.S. Medical Devices ETF
1.77%
SPDR S&P Health Care Equipment ETF
1.76%
North Shore Equity Rotation ETF
1.68%
Invesco S&P 500 Equal Weight Health Care ETF
1.6%
VanEck Morningstar SMID Moat ETF
1.2%
Humankind US Stock ETF
0.96%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.81%
查看更多
Cullen Enhanced Equity Income ETF
占比2.77%
iShares Large Cap Value Active ETF
占比2.32%
First Trust Indxx Medical Devices ETF
占比1.96%
iShares U.S. Medical Devices ETF
占比1.77%
SPDR S&P Health Care Equipment ETF
占比1.76%
North Shore Equity Rotation ETF
占比1.68%
Invesco S&P 500 Equal Weight Health Care ETF
占比1.6%
VanEck Morningstar SMID Moat ETF
占比1.2%
Humankind US Stock ETF
占比0.96%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
占比0.81%
分红派息
近5年累计派现
2.75B
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Feb 11, 2025
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 01, 2025 going ex on Feb 28, 2025 with reinvestment option
Feb 28, 2025
Apr 01, 2025
Feb 28, 2025
Nov 11, 2024
BAX.NB Final Cash Dividend of gross USD 0.17 paid on Jan 02, 2025 going ex on Nov 29, 2024 with reinvestment option
Nov 29, 2024
Jan 02, 2025
Nov 29, 2024
Jul 16, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 01, 2024 going ex on Aug 30, 2024 with reinvestment option
Aug 30, 2024
Oct 01, 2024
Aug 30, 2024
May 07, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 01, 2024 going ex on May 31, 2024 with reinvestment option
May 31, 2024
Jul 01, 2024
May 31, 2024
Feb 12, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 01, 2024 going ex on Feb 29, 2024 with reinvestment option
Mar 01, 2024
Apr 01, 2024
Feb 29, 2024
Nov 14, 2023
BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 02, 2024 going ex on Nov 30, 2023 with reinvestment option
Dec 01, 2023
Jan 02, 2024
Nov 30, 2023
Jul 18, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 02, 2023 going ex on Aug 31, 2023 with reinvestment option
Sep 01, 2023
Oct 02, 2023
Aug 31, 2023
May 01, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 03, 2023 going ex on Jun 01, 2023
Jun 02, 2023
Jul 03, 2023
Jun 01, 2023
Feb 14, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 03, 2023 going ex on Feb 23, 2023 with reinvestment option
Feb 24, 2023
Apr 03, 2023
Feb 23, 2023
Nov 15, 2022
BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 03, 2023 going ex on Dec 01, 2022
Dec 02, 2022
Jan 03, 2023
Dec 01, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
